Methods for noninvasive measurement of tissue iron in Cooley's anemia

Annals of the New York Academy of Sciences

Volumn 1054, Issue , 2005, Pages 358-372

  Sheth, Sujit ^a,e   Tang, Haiying ^a   Jensen, Jens H ^b   Altmann, Karen ^a   Prakash, Ashwin ^a   Printz, Beth F ^a   Hordof, Alan J ^a   Tosti, Christina L ^a   Azabagic, Andjela ^a   Swaminathan, Srirama ^c   Brown, Truman R ^a   Olivieri, Nancy F ^d   Brittenham, Gary M ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c PHILIPS HEALTHCARE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e Harkness Pavilion ^*  (United States)

Author keywords

Iron; Magnetic resonance; Magnetic susceptibility; Thalassemia

Indexed keywords

DEFEROXAMINE; FERRITIN; HEMOSIDERIN; IRON;

ADULT; BETA THALASSEMIA; BLOOD TRANSFUSION; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROCARDIOGRAM; ERYTHROCYTE TRANSFUSION; FEMALE; HEART MUSCLE; HUMAN; IRON CHELATION; IRON OVERLOAD; IRON STORAGE; LIVER BIOPSY; LIVER LEVEL; MAGNETIC SUSCEPTOMETRY; MAGNETISM; MALE; METHODOLOGY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; THALASSEMIA MAJOR; TISSUE LEVEL;

EID: 29744459634     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1345.044     Document Type: Conference Paper

References (66)

1. BRITTENHAM, G.M. & D.G. BADMAN. 2003. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 101: 15-19.
2. JENSEN, P.D. 2004. Evaluation of iron overload. Br. J. Haematol. 124: 697-711.
3. ANDERSON, L.J., S. HOLDEN, B. DAVIS, et al. 2001. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J. 22: 2171-2179.
4. JENSEN, P.D., F.T. JENSEN, T. CHRISTENSEN, et al. 2001. Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload. MAGMA 12: 153-166.
5. CHAN, Y.L., C.K. LI, C.W. LAM, et al. 2001. Liver iron estimation in beta-thalassaemia: comparison of MRI biochemical assay and histological grading. Clin. Radiol. 56: 911-916.
6. FENZI, A., M. BORTOLAZZI, P. MARZOLA, et al. 2001. In vivo investigation of hepatic iron overload in rats using T2 maps: quantification at high intensity field (4.7-T). J. Magn. Reson. Imaging 13: 392-396.
7. GOSSUIN, Y., P. GILLIS & F. LO BUE. 2002. Susceptibility-induced T(2)-shortening and unrestricted diffusion. Magn. Reson. Med. 47: 194-195.
8. POMERANTZ, S. & E.S. SIEGELMAN. 2002. MR imaging of iron depositional disease. Magn. Reson. Imaging Clin. North Am. 10: 105-120.
9. WANG, Z.J., J.C. HASELGROVE, M.B. MARTIN, et al. 2002. Evaluation of iron overload by single voxel MRS measurement of liver T2. J. Magn. Reson. Imaging 15: 395-400.
10. SALO, S., A. ALANEN, R. LEINO, et al. 2002. The effect of haemosiderosis and blood transfusions on the T2 relaxation time and 1/T2 relaxation rate of liver tissue. Br. J. Radiol. 75: 24-27.
11. JENSEN, J.H. & R. CHANDRA. 2002. Theory of nonexponential NMR signal decay in liver with iron overload or superparamagnetic iron oxide particles. Magn. Reson. Med. 47: 1131-1138.
12. CLARK, P.R., W. CHUA-ANUSORN & T.G. ST. PIERRE. 2003. Bi-exponential proton transverse relaxation rate (R2) image analysis using RF field intensity-weighted spin density projection: potential for R2 measurement of iron-loaded liver. Magn. Reson. Imaging 21: 519-530.
13. CLARK, P.R., W. CHUA-ANUSORN & T.G. ST. PIERRE. 2003. Proton transverse relaxation rate (R2) images of liver tissue; mapping local tissue iron concentrations with MRI [corrected]. Magn. Reson. Med. 49: 572-575.
14. JENSEN, P.D., F.T. JENSEN, T. CHRISTENSEN, et al. 2003. Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias. Blood 101: 91-96.
15. JENSEN, P.D., F.T. JENSEN, T CHRISTENSEN, et al. 2003. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with desferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 101: 4632-4639.
16. GALIA, M., M. MIDIRI, V. BARTOLOTTA, et al. 2003. Potential myocardial iron content evaluation by magnetic resonance imaging in thalassemia major patients treated with deferoxamine or deferiprone during a randomized multicenter prospective clinical study. Hemoglobin 27: 63-76.
17. FENZI, A., M. BORTOLAZZI & P. MARZOLA. 2003. Comparison between signal-to-noise ratio, liver-to-muscle ratio, and 1/T2 for the noninvasive assessment of liver iron content by MRI. J. Magn. Reson. Imaging 17: 589-592.
18. WESTWOOD, M.A., L.J. ANDERSON, D.N. FIRMIN, et al. 2003. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J. Magn. Reson. Imaging 18: 616-620.
19. WESTWOOD, M., L.J. ANDERSON, D.N. FIRMIN, et al. 2003. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J. Magn. Reson. Imaging 18: 33-39.
20. ARGYROPOULOU, M.I., D.N. KIORTSIS & S.C. EFREMIDIS. 2003. MRI of the liver and the pituitary gland in patients with beta-thalassemia major: does hepatic siderosis predict pituitary iron deposition? Eur. Radiol. 13: 12-16.
21. MANCUSO, L., G. PANZARELLA, T.V. BARTOLOTTA, et al. 2003. Cardiac complications in thalassemia: noninvasive detection methods and new directions in the clinical management. Expert Rev. Cardiovasc. Ther. 1: 439-452.
22. KELLENBERGER, C.J., M. SCHMUGGE, T. SAURENMANN, et al. 2004. Radiographic and MRI features of deferiprone-related arthropathy of the knees in patients with beta-thalassemia. Am. J. Roentgenol. 183: 989-994.
23. ANDERSON, L.J., M. WESTWOOD, S. HOLDEN, et al. 2004. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br. J. Haematol. 127: 348-355.
24. JOHNSTON, J.D. 2004. Non-invasive assessment of hepatic iron stores by MRI. Ann. Clin. Biochem. 41: 254.
25. ALUSTIZA, J.M., J. ARTETXE, A. CASTIELLA, et al. 2004. MR quantification of hepatic iron concentration. Radiology 230: 479-484.
26. VOSKARIDOU, E., M. DOUSKOU, E. TERPOS, et al. 2004. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br. J. Haematol. 126: 736-742.
27. ST. PIERRE, T.G., P.R. CLARK & W. CHUA-ANUSORN. 2004. Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed. 17: 446-458.
28. WOOD, J.C., J.M. TYSZKA, S. CARSON, et al. 2004. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 103: 1934-1936.
29. HAACKE, E.M., Y. XU, Y.C. CHEN, et al. 2004. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 52: 612-618.
30. GOSSUIN, Y., R.N. MULLER & P. GILLIS. 2004. Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification. NMR Biomed. 17: 427-432.
31. GANDON, Y., D. OLIVIE, D. GUYADER, et al. 2004. Non-invasive assessment of hepatic iron stores by MRI. Lancet 363: 357-362.
32. PERIFANIS, V., M. ECONOMOU, A. CHRISTOFORIDES, et al. 2004. Evaluation of iron overload in beta-thalassemia patients using magnetic resonance imaging. Hemoglobin 28: 45-49.
33. OOI, G.C., P.L. KHONG, G.C. CHAN, et al. 2004. Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients. Br. J. Haematol. 124: 385-390.
34. MARTIN, D.R. 2004. Liver-iron assay by MRI. Lancet 363: 341-342.
35. CHU, Z., A.R. COHEN, R. MUTHUPILLAI, et al. 2004. MRI measurement of hepatic magnetic susceptibility-phantom validation and normal subject studies. Magn. Reson. Med. 52: 1318-1327.
36. WOOD, J.C., C. ENRIQUEZ, N. GHUGRE, et al. 2005. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle-cell disease patients. Blood 106: 1460-1465.
37. WESTWOOD, M.A., M.N. SHEPPARD, M. AWOGBADE, et al. 2005. Myocardial biopsy and T2* magnetic resonance in heart failure due to thalassaemia. Br. J. Haematol. 128: 2.
38. ARGYROPOULOU, M.I. & D.N. KIORTSIS. 2005. MRI of the hypothalamic-pituitary axis in children. Pediatr. Radiol. In press.
39. WANG, Z.J., L. LIAN, Q. CHEN, et al. 2005. 1/T2 and magnetic susceptibility measurements in a gerbil cardiac iron overload model. Radiology 234: 749-755.
40. ST. PIERRE, T.G., P.R. CLARK, W CHUA-ANUSORN, et al. 2005. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105: 855-861.
41. SIEGELMAN, E.S., D.G. MITCHELL & R.C. SEMELKA. 1996. Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 199: 13-22.
42. HARRISON, P.M. & P. AROSIO. 1996. The ferritins: molecular properties, iron storage function, and cellular regulation. Biochim. Biophys. Acta 1275: 161-203.
43. CHASTEEN, N.D. & P.M. HARRISON. 1999. Mineralization in ferritin: an efficient means of iron storage. J. Struct. Biol. 126: 182-194.
44. WIXOM, R.L., L. PRUTKIN & H.N. MUNRO. 1980. Hemosiderin: nature, formation, and significance. Int. Rev. Exp. Pathol. 22: 193-225.
45. CHUA-ANUSORN, W. & J. WEBB. 2000. Infrared spectroscopic studies of nanoscale iron oxide deposits isolated from human thalassemic tissues. J. Inorg. Biochem. 79: 303-309.
46. ST. PIERRE, T.G., W. CHUA-ANUSORN, J. WEBB, et al. 1998. The form of iron oxide deposits in thalassemic tissues varies between different groups of patients: a comparison between Thai beta-thalassemia/hemoglobin E patients and Australian beta-thalassemia patients. Biochim. Biophys. Acta 1407: 51-60.
47. ST. PIERRE, T.G., K.C. TRAN, J. WEBB, et al. 1991. Organ-specific crystalline structures of ferritin cores in beta-thalassemia/hemoglobin E. Biol. Metals 4: 162-165.
48. WARD, R.J., M.J. O'CONNELL, D.P. DICKSON, et al. 1989. Biochemical studies of the iron cores and polypeptide shells of haemosiderin isolated from patients with primary or secondary haemochromatosis. Biochim. Biophys. Acta 993: 131-133.
49. DICKSON, D.P., N.M. REID, S. MANN, et al. 1988. Mossbauer spectroscopy, electron microscopy, and electron diffraction studies of the iron cores in various human and animal haemosiderins. Biochim. Biophys. Acta 957: 81-90.
50. MANN, S., V.J. WADE, D.P. DICKSON, et al. 1988. Structural specificity of haemosiderin iron cores in iron-overload diseases. FEBS Lett. 234: 69-72.
51. ALLEN, P.D., T.G. ST. PIERRE, W. CHUA-ANUSORN, et al. 2000. Low-frequency low-field magnetic susceptibility of ferritin and hemosiderin. Biochim. Biophys. Acta 1500: 186-196.
52. BROOKS, R.A., J. VYMAZAL, R.B. GOLDFARB, et al. 1998. Relaxometry and magnetometry of ferritin. Magn. Reson. Med. 40: 227-235.
53. JOHNSTON, D.L., L. RICE, G.W. VICK, et al. 1989. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am. J. Med. 87: 40-47.
54. THOMSEN, C., P. WIGGERS, H. RING-LARSEN, et al. 1992. Identification of patients with hereditary haemochromatosis by magnetic resonance imaging and spectroscopic relaxation time measurements. Magn. Reson. Imaging 10: 867-879.
55. GOSSUIN, Y., A. ROCH, R. MULLER, et al. 2000. Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange. Magn. Reson. Med. 43: 237-243.
56. OLIVIERI, N.F., G.M. BRITTENHAM, C.E. MCLAREN, et al. 1998. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N. Engl. J. Med. 339: 417-423.
57. TANG, H., J.H. JENSON, S. SHETH, et al. 2005. MR measurement of ferritin and hemosiderin iron in patients with iron overload. Proc. Int. Soc. Magn. Reson. Med. 13: 1880.
58. WOOD, J.C., M. OTTO-DUESSEL, et al. 2004. Cardiac MRI (T2, T2*) predicts cardiac iron in the gerbil model of iron cardiomyopathy. Blood 104: 111a [abstract].
59. COLLINS, W. & W.H. TAYLOR. 1987. Determination of iron in cardiac and liver tissues by plasma emission spectroscopy. Ann. Clin. Biochem. 24: 483-487.
60. HERSHKO, C., M.D. CAPPELLINI, R. GALANELLO, et al. 2004. Purging iron from the heart. Br. J. Haematol. 125: 545-551.
61. 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat. Med. 9: 1187-1194.
62. SHARMA, N., J. BUTTERWORTH, B.T. COOPER, et al. 2005. The emerging role of the liver in iron metabolism. Am. J. Gastroenterol. 100: 201-206.
63. ANGELUCCI, E., G.M. BRITTENHAM, C.E. MCLAREN, et al. 2000. Hepatic iron concentration and total body iron stores in thalassemia major. N. Engl. J. Med. 343: 327-331.
64. PORTER, J.B. 2001. Practical management of iron overload. Br. J. Haematol. 115: 239-252.
65. MACARINI, L., S. MARINI, A. PIETRAPERTOSA, et al. 2005. Noncardiopathic and cardiopathic beta thalassemic patients: quantitative and qualitative cardiac iron deposition evaluation with MRI. Radiol. Med. (Torino) 109: 77-90.
66. BRITTENHAM, G.M., P.M. GRIFFITH, A.W NIENHUIS, et al. 1994. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N. Engl. J. Med. 331: 567-573.